Ticker League

Operating Cash Flow for Gilead Sciences (GILD)

As of · Reported

Metric

Latest period

$2.54B

YoY change

-7.5%

5Y CAGR

+4.2%

Peak year (2015)

$21.25B

Operating Cash Flow history chart for Gilead Sciences (GILD) from 1990 to 2025

Latest: $10.02B

Operating Cash Flow growth chart for Gilead Sciences (GILD) from 1990 to 2025

Latest: -7.5%

Operating Cash Flow history table for Gilead Sciences (GILD) from 1990 to 2025

  • 2025$10.02B-7.5%
  • 2024$10.83B+35.2%
  • 2023$8.01B-11.8%
  • 2022$9.07B-20.3%
  • 2021$11.38B+39.4%
  • 2020$8.17B-10.7%
  • 2019$9.14B+8.9%
  • 2018$8.40B-29.4%
  • 2017$11.90B-30.2%
  • 2016$17.05B-19.8%
  • 2015$21.25B+65.8%
  • 2014$12.82B+312.8%
  • 2013$3.10B-2.8%
  • 2012$3.19B-12.2%
  • 2011$3.64B+28.4%
  • 2010$2.83B-8.0%
  • 2009$3.08B+43.7%
  • 2008$2.14B+21.4%
  • 2007$1.77B+44.9%
  • 2006$1.22B+72.6%
  • 2005$705.64M+38.9%
  • 2004$507.96M+116.5%
  • 2003$234.61M+215.3%
  • 2002$74.41M-158.6%
  • 2001−$126.98M+232.4%
  • 2000−$38.20M-39.0%
  • 1999−$62.60M+22.0%
  • 1998−$51.30M-5.9%
  • 1997−$54.50M+230.3%
  • 1996−$16.50M-28.3%
  • 1995−$23.00M-16.1%
  • 1994−$27.40M—
  • 1992−$8.90M+140.5%
  • 1991−$3.70M+54.2%
  • 1990−$2.40M—

Operating Cash Flow values are taken from Gilead Sciences's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Cash Flow at Gilead Sciences (GILD)

Operating Cash Flow for Gilead Sciences (GILD): headline value $2.54B · YoY -7.5%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

In 2025, Gilead Sciences (GILD) operating cash flow totalled $10.02B – declined 7.5% year-over-year.

Through 2020–2025 (5 years), Gilead Sciences operating cash flow delivered a +4.2% annualised rate; with mixed annual results across the window.

Gilead Sciences operating cash flow plunged from $21.25B in 2015 to $10.02B in 2025, a 52.9% drawdown.

$21.25B stands as the all-time-high annual operating cash flow, posted in 2015, against a low of −$126.98M during 2001.

Gilead Sciences Operating Cash Flow by Year

Gilead Sciences Operating Cash Flow 2025: $10.02B

Gilead Sciences operating cash flow in 2025 was $10.02B, declined 7.5% below 2024.

Gilead Sciences Operating Cash Flow 2024: $10.83B

2024's operating cash flow for Gilead Sciences came in at $10.83B, surged 35.2% from 2023.

Gilead Sciences Operating Cash Flow 2023: $8.01B

Gilead Sciences posted operating cash flow of $8.01B in 2023, declined 11.8% below 2022.

Gilead Sciences Operating Cash Flow 2022: $9.07B

In 2022, Gilead Sciences reported operating cash flow of $9.07B, declined 20.3% below 2021.

Gilead Sciences Operating Cash Flow 2021: $11.38B

Gilead Sciences operating cash flow in 2021 was $11.38B.

See more financial history for Gilead Sciences (GILD).

Sector peers by Operating Cash Flow

Healthcare peers of Gilead Sciences (GILD), ranked by their latest operating cash flow

Frequently asked questions

Gilead Sciences (GILD) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation